Microorganisms engineered to reduce hyperphenylalaninemia
US12171790B2 · kind B2 · utility
1Cited by
20References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2023 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.